Impiego dell’idrogeno per la sostenibilità delle flotte del Trasporto Pubblico Locale

La domanda mondiale di energia è in costante aumento e le attuali tecnologie per la produzione di energia dai combustibili fossili emettono anidride carbonica (CO2). La combinazione di idrogeno ed elettricità è un’incoraggiante soluzione verso la realizzazione di un futuro a “zero emissioni” basato sull’energia sostenibile. L’idrogeno molecolare è un elemento scarso in natura; la sua produzione è quasi esclusivamente da fonti fossili. Se prodotto tramite elettrolisi da fonti di energia naturali è possibile produrre idrogeno senza significative emissioni di anidride carbonica ma con costi ancora troppo elevati; tali metodologie al giorno d’oggi sono ancora poco sviluppate e non in grado di competere con le tecniche industriali più consolidate di derivazione dell’ idrogeno dalle fonti fossili. Un altro ostacolo risiede nella difficoltà di immagazzinarlo e trasportarlo; viene stoccato con sicurezza in grandi contenitori industriali o in recipienti ad alta pressione. Occorre garantire una sufficiente capacità di stoccaggio nelle applicazioni per autoveicoli, così da ottenere un buon equilibrio tra autonomia di guida e spazio di stoccaggio. Nell’autotrazione possono essere utilizzate le fuel cells che assicurano un uso efficiente dell’idrogeno; convertono l’energia chimica dell’idrogeno in energia elettrica, acqua e calore, assicurando rendimenti di conversione energetica molto alti, oltre a garantire una notevole silenziosità dovuta essenzialmente all’assenza di organi rotanti. Le fuel cells possono essere applicate anche ai veicoli dedicati al trasporto pubblico locale, garantendo l’abbattimento delle emissioni nocive nelle aeree urbane al fine del benessere dei cittadini. Tper è da anni attiva sul fronte della mobilità sostenibile; vanta una delle flotte di autobus più “verdi” d’Italia e in un futuro molto prossimo incrementerà ancora di più la percentuale di autobus a basse emissioni puntando soprattutto all’acquisto di autobus ad idrogeno.

Controllo emissioni MCI alimentati ad idrogeno

Il tema principale della tesi sono le emissioni di motori a combustione interna alimentati ad idrogeno. Dopo un'introduzione inziale, nella quale si spiegano le proprietà dell'idrogeno e i passaggi per ottenerlo, si entra nello specifico utilizzo di esso come combustibile e nelle modifiche da apportare ad un comune MCI. Nella parte centrale della tesi vengono prese in considerazione le anomalie di combustione ed alcune soluzioni per esse, soffermandosi in particolare sulla detonazione. Nella parte finale, invece, vengono trattate le emissioni inquinanti e i sistemi di post-trattamento dei gas di scarico, cercando di individuare soluzioni ottimali. Anche quando ci si concentra su altri aspetti però si pone sempre un occhio di riguardo alle possibili emissioni inquinanti dettate dalle condizioni descritte.

Sistemi di testing per celle a combustibile

La tesi tratta funzionamento, ottimizzazione e applicazioni delle celle a combustibile PEM (PEM Fuel cells) che sono dispositivi capaci di convertire reversibilmente l’energia chimica contenuta nel combustibile in energia elettrica, energia termica e prodotti di reazione. Vengono analizzati gli effetti di temperatura, pressione e umidità sulla cinetica, sulle prestazioni, sull’OCV, sulla conduttività della membrana e sul trasferimento di massa. In generale, per utilizzare una cella a combustibile PEM, ogni componente, materiale e l'assemblaggio delle celle dovrebbe essere realizzabile e ottimizzato per ottenere alte prestazioni. Vengono, quindi, trattate le tecniche di test e diagnosi che rappresentano il modo più popolare e affidabile per convalidare i progetti di questi componenti e della cella combustibile stessa. Inoltre, si affronta il discorso sull’idrogeno definito come vettore di energia che ha assunto un ruolo di primo piano per un mercato a basse emissioni; infatti ha un grande potenziale come combustibile alternativo e assume un ruolo centrale nello scenario energetico del futuro. Infine, si parla anche di applicazioni pratiche ed esistenti riguardanti le celle a combustibile in veicoli, come le proposte di Nuvera ed EH Group.

Polymerization of isatin towards polymers for anion exchange membranes and gas separation applications

In a world where the problem of energy resources, pollution and all aspects related to these issues become more and more dominant, a greater commitment is needed in the search for solutions. The goal of this project is to make a contribution to the research and development of new materials to reduce the environmental impact in some fields. First of all, we tried to synthesize and prepare an isatin-based membrane which has the potential for use in separating industrial gases. Furthermore, ion exchange membranes, specifically hydroxide exchange membranes (HEMs) derived from the same product can be developed for fuel cells (HEMFC) applications. These materials are essential for energy conversion and storage. The most difficult challenge is to guarantee their thermal stability and stability in corrosive environments such as alkali without losing efficiency. In recent years the poly- hydroxyalkylation catalysed with superacids, e.g. TFSA, has become increasingly studied. This reaction is exploited for the synthesis of the compounds of this thesis. After a preliminary optimization of the reaction conditions it was concluded that due to the rigidity and excessive reactivity of the system, it was not possible to obtain the isatin-based membrane to evaluate the gas separation properties. The synthesis of precursor materials for HEMs was successful by using 1-(4-bromobutyl)indoline-2,3-dione (BID) instead of isatin. A characterization of the obtained polymers was carried out using NMR, TGA and DSC analyses, and subsequently the membranes were functionalized with different ammonium-based cations. Unfortunately, this last step was not successful due to the appearance of side reactions. Future studies on the mechanism and kinetics of the reaction solve this obstacle.

Fermentation of Groundnut Shell Enzymatic Hydrolysate for Fuel Ethanol Production by Free and Sorghum Stalks Immobilized Cells of Pichia stipitis NCIM 3498

Groundnut shell (GS), after separation of pod, is readily available as a potential feedstock for production of fermentable sugars. The substrate was delignified with sodium sulfite. The delignified substrate released 670 mg/g of sugars after enzymatic hydrolysis (50 degrees C, 120 rpm, 50 hrs) using commercial cellulases (Dyadic Xylanase PLUS, Dyadic Inc. USA). The groundnut shell enzymatic hydrolysate (45.6 g/L reducing sugars) was fermented for ethanol production with free and sorghum stalks immobilized cells of Pichia stipitis NCIM 3498 under submerged cultivation conditions. Immobilization of yeast cells on sorghum stalks were confirmed by scanning electron microscopy (SEM). A maximum of ethanol production (17.83 g/L, yield 0.44 g/g and 20.45 g/L, yield 0.47 g/g) was observed with free and immobilized cells of P. stipitis respectively in batch fermentation conditions. Recycling of immobilized cells showed a stable ethanol production (20.45 g/L, yield 0.47 g/g) up to 5 batches followed by a gradual downfall in subsequent cycles.

A novel electrocatalyst support with proton conductive properties for polymer electrolyte membrane fuel cell applications

The objective of this study is to graft the Surface of carbon black, by chemically introducing polymeric chains (Nafion (R) like) with proton-conducting properties. This procedure aims for a better interaction of the proton-conducting phase with the metallic catalyst particles, as well as hinders posterior support particle agglomeration. Also loss of active surface call be prevented. The proton conduction between the active electrocatalyst site and the Nafion (R) ionomer membrane should be enhanced, thus diminishing the ohmic drop ill the polymer electrolyte membrane fuel cell (PEMFC). PtRu nanoparticles were supported on different carbon materials by the impregnation method and direct reduction with ethylene glycol and characterized using amongst others FTIR, XRD and TEM. The screen printing technique was used to produce membrane electrode assemblies (MEA) for single cell tests in H(2)/air(PEMFC) and methanol operation (DMFC). In the PEMFC experiments, PtRu supported on grafted carbon shows 550 mW cm(-2) gmetal(-1) power density, which represents at least 78% improvement in performance, compared to the power density of commercial PtRu/C ETEK. The DMFC results of the grafted electrocatalyst achieve around 100% improvement. The polarization Curves results clearly show that the main Cause of the observed effect is the reduction in ohmic drop, caused by the grafted polymer. (C) 2009 Elsevier B.V. All rights reserved.

Effect of Annatto on Micronuclei Induction by Direct and Indirect Mutagens in HepG2 Cells

Annatto (AN), a natural food colorant rich in carotenoids, has been reported as being an effective antioxidant, but little is known about its potential chemopreventive properties. In this Study, we evaluated the ability of AN to protect human hepatoma cells (HepG2) from micronucleus (MN) induction against three different mutagens: benzo(a)pyrene (B(a)P), doxorubicin (DXR), and methyl methanesulfonate (MMS). In an attempt to clarify the possible mechanism of anti mutagenicity of AN, three protocols of treatment were applied (pretreatment; simultaneous treatment, and post-treatment with AN following treatment with the mutagens). Also, cells exposed only to AN were assayed for cytotoxicity and mutagenicity. A dosage up to 10 mu g/ml of AN was devoid of mutagenic activity. Protective effects were seen on micronuclei induced by B(a)P and DXR using pre and simultaneous treatment, but AN had no significant effect on MN induction by MMS in any of the protocols. Our results also show that exposure of cells to concentrations of AN higher than 10 mu g/ml decreased cell viability. Taken together, our findings indicate that AN presents antimutagenic activity in vitro, but its protective effect is dependent on the mutagen and on type of treatment suggesting its potential use as a chemopreventive agent. Environ. Mol. Mutagen. 50:808-814, 2009. (C) 2009 Wiley-Liss, Inc.

Chemical treatment of Escherichia coli. II. Direct extraction of recombinant protein from cytoplasmic inclusion bodies in intact cells

A method is presented for the direct extraction of the recombinant protein Long-R-3-IGF-I from inclusion bodies located in the cytoplasm of intact Escherichia coli cells. Chemical treatment with 6M urea, 3 mM EDTA, and 20 mM dithiothreitol (DTT) at pH 9.0 proved an effective combination for extracting recombinant protein from intact cells. Comparable levels of Long-R-3-IGF-I were recovered by direct extraction as achieved by in vitro dissolution following mechanical disruption. However, the purity of directly extracted recombinant protein was lower due to contamination by bacterial cell components. The kinetics of direct extraction are described using a first-order equation with the time constant of 3 min. Urea appears important for permeabilization of the cell and dissolution of the inclusion body. Conversely, EDTA is involved in permeabilization of the cell wall and DTT enhances protein release. pH proved to be important with lower levels of protein release achieved at low pH values (

Synthesis of biodiesel from wastes of food industry via direct transesterification with methanol/carbon dioxide mixtures

Dissertation presented at Faculdade de Ciências e Tecnologia from Universidade Nova de Lisboa to obtain the degree of Master in Chemical and Biochemical Engineering

Direct binding of peptides to MHC class I molecules on living cells. Analysis at the single cell level.

To directly assess the binding of exogenous peptides to cell surface-associated MHC class I molecules at the single cell level, we examined the possibility of combining the use of biotinylated peptide derivatives with an immunofluorescence detection system based on flow cytometry. Various biotinylated derivatives of the adenovirus 5 early region 1A peptide 234-243, an antigenic peptide recognized by CTL in the context of H-2Db, were first screened in functional assays for their ability to bind efficiently to Db molecules on living cells. Suitable peptide derivatives were then tested for their ability to generate positive fluorescence signals upon addition of phycoerythrin-labeled streptavidin to peptide derivative-bearing cells. Strong fluorescent staining of Db-expressing cells was achieved after incubation with a peptide derivative containing a biotin group at the C-terminus. Competition experiments using the unmodified parental peptide as well as unrelated peptides known to bind to Kd, Kb, or Db, respectively, established that binding of the biotinylated peptide to living cells was Db-specific. By using Con A blasts derived from different H-2 congenic mouse strains, it could be shown that the biotinylated peptide bound only to Db among > 20 class I alleles tested. Moreover, binding of the biotinylated peptide to cells expressing the Dbm13 and Dbm14 mutant molecules was drastically reduced compared to Db. Binding of the biotinylated peptide to freshly isolated Db+ cells was readily detectable, allowing direct assessment of the relative amount of peptide bound to distinct lymphocyte subpopulations by three-color flow cytometry. While minor differences between peripheral T and B cells could be documented, thymocytes were found to differ widely in their peptide binding activity. In all cases, these differences correlated positively with the differential expression of Db at the cell surface. Finally, kinetic studies at different temperatures strongly suggested that the biotinylated peptide first associated with Db molecules available constitutively at the cell surface and then with newly arrived Db molecules.

Vitamin D has a direct immunomodulatory effect on CD8+ T cells of patients with early multiple sclerosis and healthy control subjects.

Little is known on a putative effect of vitamin D on CD8+ T cells. Yet, these cells are involved in the immmunopathogenesis of MS. We assessed the cytokine profile of EBV-specific CD8+ T cells of 10 early MS patients and 10 healthy control subjects with or without 1,25(OH)(2)D(3) and found that, with 1,25(OH)(2)D(3), these cells secreted less IFN-γ and TNF-α and more IL-5 and TGF-β. CD4+ T cell depletion or even culture with CD8+ T cells only did not abolish the immunomodulatory effect of 1,25(OH)(2)D(3) on CD8+ T cells, suggesting that 1,25(OH)(2)D(3) can act directly on CD8+ T cells.

Direct presentation of a melanocyte-associated antigen in peripheral lymph nodes induces cytotoxic CD8+ T cells.

Encounter of self-antigens in the periphery by mature T cells induces tolerance in the steady-state. Hence, it is not understood why the same peripheral antigens are also promiscuously expressed in the thymus to mediate central tolerance. Here, we analyzed CD8(+) T-cell tolerance to such an antigen constituted by ovalbumin under the control of the tyrosinase promoter. As expected, endogenous CD8(+) T-cell responses were altered in the periphery of transgenic mice, resulting from promiscuous expression of the self-antigen in mature medullary epithelial cells and deletion of high-affinity T cells in the thymus. In adoptive T-cell transfer experiments, we observed constitutive presentation of the self-antigen in peripheral lymph nodes. Notably, this self-antigen presentation induced persisting cytotoxic cells from high-affinity CD8(+) T-cell precursors. Lymph node resident melanoblasts expressing tyrosinase directly presented the self-antigen to CD8(+) T cells, independently of bone marrow-derived antigen-presenting cells. This peripheral priming was independent of the subcellular localization of the self-antigen, indicating that this mechanism may apply to other melanocyte-associated antigens. Hence, central tolerance by promiscuous expression of peripheral antigens is a mandatory, rather than a superfluous, mechanism to counteract the peripheral priming, at least for self-antigens that can be directly presented in lymph nodes. The peripheral priming by lymph node melanoblasts identified here may constitute an advantage for immunotherapies based on adoptive T-cell transfer.

Direct detection of a BRAF mutation in total RNA from melanoma cells using cantilever arrays.

Malignant melanoma, the deadliest form of skin cancer, is characterized by a predominant mutation in the BRAF gene. Drugs that target tumours carrying this mutation have recently entered the clinic. Accordingly, patients are routinely screened for mutations in this gene to determine whether they can benefit from this type of treatment. The current gold standard for mutation screening uses real-time polymerase chain reaction and sequencing methods. Here we show that an assay based on microcantilever arrays can detect the mutation nanomechanically without amplification in total RNA samples isolated from melanoma cells. The assay is based on a BRAF-specific oligonucleotide probe. We detected mutant BRAF at a concentration of 500 pM in a 50-fold excess of the wild-type sequence. The method was able to distinguish melanoma cells carrying the mutation from wild-type cells using as little as 20 ng µl(-1) of RNA material, without prior PCR amplification and use of labels.

JARID2 is a direct target of the PAX3-FOXO1 fusion protein and inhibits myogenic differentiation of rhabdomyosarcoma cells.

Rhabdomyosarcomas (RMS) are the most frequent soft-tissue sarcoma in children and characteristically show features of developing skeletal muscle. The alveolar subtype is frequently associated with a PAX3-FOXO1 fusion protein that is known to contribute to the undifferentiated myogenic phenotype of RMS cells. Histone methylation of lysine residues controls developmental processes in both normal and malignant cell contexts. Here we show that JARID2, which encodes a protein known to recruit various complexes with histone-methylating activity to their target genes, is significantly overexpressed in RMS with PAX3-FOXO1 compared with the fusion gene-negative RMS (t-test; P < 0.0001). Multivariate analyses showed that higher JARID2 levels are also associated with metastases at diagnosis, independent of fusion gene status and RMS subtype (n = 120; P = 0.039). JARID2 levels were altered by silencing or overexpressing PAX3-FOXO1 in RMS cell lines with and without the fusion gene, respectively. Consistent with this, we demonstrated that JARID2 is a direct transcriptional target of the PAX3-FOXO1 fusion protein. Silencing JARID2 resulted in reduced cell proliferation coupled with myogenic differentiation, including increased expression of Myogenin (MYOG) and Myosin Light Chain (MYL1) in RMS cell lines representative of both the alveolar and embryonal subtypes. Induced myogenic differentiation was associated with a decrease in JARID2 levels and this phenotype could be rescued by overexpressing JARID2. Furthermore, we that showed JARID2 binds to and alters the methylation status of histone H3 lysine 27 in the promoter regions of MYOG and MYL1 and that the interaction of JARID2 at these promoters is dependent on EED, a core component of the polycomb repressive complex 2 (PRC2). Therefore, JARID2 is a downstream effector of PAX3-FOXO1 that maintains an undifferentiated myogenic phenotype that is characteristic of RMS. JARID2 and other components of PRC2 may represent novel therapeutic targets for treating RMS patients.